Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
Initially activates TRPV1 receptors on peripheral nociceptive neurons, causing local warmth or burning. Repeated exposure leads to functional desensitisation and reduced release of pain-related neuropeptides, lowering peripheral nociceptive signalling.
Indications / reported uses
Topical relief of neuropathic pain, including postherpetic neuralgia and painful diabetic peripheral neuropathy, using the product-specific strength
Temporary relief of minor muscle and joint pain with lower-strength topical preparations; high-concentration patches require supervised application
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Capsaicin PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Capsaicin Permitted Daily Exposure (PDE) report (the Capsaicin PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Capsaicin Occupational Exposure Limit (OEL) report (the Capsaicin OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.